Cui et al. found that inhibitors of AKT and mTOR repressed the motility of liver cancer cells, decreased glucose consumption and lactate production, and hindered HK2 expression, suggesting that inhibition of the AKT/mTOR signaling axis deterred cell motility by repressing glycolysis in HCC cells [46]. Here, AKT1 is linked to liver cancer.